Prospective Study of Long‐Term Outcomes and the Patient Experience With Superior Laryngeal Nerve Block for Chronic Cough
The Laryngoscope · 2026
DOI: 10.1002/lary.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Andrew T Peachman und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University College of Medicine, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Cough, Laryngeal Nerves, Nerve Block. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To characterize long‐term response rates to the superior laryngeal nerve (SLN) block in a prospective fashion. Secondary objectives are to provide objective data to answer common pre‐procedural questions and to identify factors that predict injection outcomes.
Methods
Prospective study from April 2021 to August 2024 of adult patients with refractory chronic cough undergoing SLN block. Response was measured via a yes/no question about improvement, cough severity index (CSI), and a 1–10 Likert scale grading cough impact on quality of life (QoL) taken at baseline, 2 weeks, and 6–9 months post‐injection.
Results
One hundredtwenty‐two patients were injected for cough, representing 249 injections. At 2 weeks after injection, 63.1% endorsed improvement on yes/no questioning (“initial improvers”), with significant improvement in both CSI and QoL scores ( p < 0.001 for each). Of the initial improvers, 53.2% reported ongoing symptom improvement at long‐term follow‐up (6–9 months). Improvement occurred at an average of 4.3 days after injection and averaged 4.1 months in duration. 72.1% of improvers reported their degree of improvement as “a lot” or “completely.” Side effects occurred in 44.2% of injections and were typically mild. No cough feature or clinical factor significantly predicted a positive response to the SLN block.
Conclusion
This prospective assessment indicates that nearly 2 in 3 refractory chronic cough patients respond positively to SLN block, with ~50% of these initial improvers endorsing ongoing improvement at long‐term follow‐up. Average duration of benefit is 4 months, and side effects are common. Predictive factors of a positive response to SLN block remain undefined. Level of Evidence 4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.
- Department of Otolaryngology, Kaiser Permanente of Washington, Seattle, Washington, USA.
ORCID-Profile: Andrew T Peachman, Zachary T Root, Brandon Kim, Brad W deSilva, Laura Matrka
Zitieren
APA
Peachman, A. T., Root, Z. T., Alsavaf, M. B., Kim, B., deSilva, B. W., & Matrka, L. (2026). Prospective Study of Long‐Term Outcomes and the Patient Experience With Superior Laryngeal Nerve Block for Chronic Cough. The Laryngoscope. https://doi.org/10.1002/lary.70011
Vancouver
Peachman AT, Root ZT, Alsavaf MB, Kim B, deSilva BW, Matrka L. Prospective Study of Long‐Term Outcomes and the Patient Experience With Superior Laryngeal Nerve Block for Chronic Cough. The Laryngoscope. 2026. doi:10.1002/lary.70011
BibTeX
@article{Peachman2026,
author = {Peachman, Andrew T and Root, Zachary T and Alsavaf, Mohammad Bilal and Kim, Brandon and deSilva, Brad W and Matrka, Laura},
title = {Prospective Study of Long‐Term Outcomes and the Patient Experience With Superior Laryngeal Nerve Block for Chronic Cough},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70011}
}
EUVIMED